COMBINATION OF REBOXETINE AND A MUSCARINIC RECEPTOR ANTAGONIST (MRA) FOR USE IN TREATING SLEEP APNEA
Pharmaceutical compositions comprising reboxetine or a pharmaceutically acceptable salt thereof and a muscarinic receptor antagonist (MRA) and methods of treating sleep apnea comprising administering reboxetine or a pharmaceutically acceptable salt thereof and an MRA are described herein. In some em...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pharmaceutical compositions comprising reboxetine or a pharmaceutically acceptable salt thereof and a muscarinic receptor antagonist (MRA) and methods of treating sleep apnea comprising administering reboxetine or a pharmaceutically acceptable salt thereof and an MRA are described herein. In some embodiments, the MRA is oxybutynin or (R)-oxybutynin or a pharmaceutically acceptable salt thereof. |
---|